Company's new patent-pending needles offer the next level of dependability, with a new, highly visible extraction collar
LEXINGTON, Ky., Nov. 15, 2022 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has released an upgraded version of its best-selling Ideal® D3™ detectable needles, designed to be six times more detectable than the conventional and stainless-steel needles.
Read more at prnewswire.com